BRIC Market Report Suite for Immunology Drugs 2017 - MedSuite

  • ID: 4457178
  • Report
  • Region: BRIC
  • 1261 pages
  • iData Research
1 of 4

FEATURED COMPANIES

  • AbbVie Inc.
  • AstraZeneca Plc
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • Merck KGaA
  • Novartis AG
  • MORE
Besides the typical market data found above you will be able to discover how these diseases have been trending over time, their epidemiology, drivers and limiters of these markets, Porter’s Five Forces analysis, clinical trials, a pipeline of products coming out soon, mergers and acquisitions, company profiles and SWOT analyses.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AbbVie Inc.
  • AstraZeneca Plc
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • Merck KGaA
  • Novartis AG
  • MORE
Report Guidance

Market Definition

Research Methodology

Executive Summary

Disease Overview
Rheumatoid Arthritis
Introduction
Causes and Disease Progression
Diagnosis and Treatment Options
Symptoms and Complications
Epidemiology
Crohn’s Disease
Introduction
Causes and Disease Progression
Diagnosis and Treatment Options
Symptoms and Complications
Epidemiology
Ankylosing Spondylitis
Introduction
Causes and Disease Progression
Diagnosis and Treatment Options
Symptoms and Complications
Epidemiology
Psoriasis
Introduction
Causes and Disease Progression
Diagnosis and Treatment Options
Symptoms and Complications
Epidemiology
Ulcerative Colitis
Introduction
Causes and Disease Progression
Diagnosis and Treatment Options
Symptoms and Complications
Epidemiology

Product Assessment
Clinical Trials Overview
Pipeline Analysis
Promising new drugs for Ankylosing Spondylitis in the pipeline
Promising new drugs for Crohn's Disease in the pipeline
Promising new drugs for Psoriasis in the pipeline
Promising new drugs for Rheumatoid Arthritis in the pipeline
Key Marketed Products Portfoilo
Orencia (abatacept)
Humira (adalimumab)
Cimzia (certolizumab)
Enbrel (etanercept)
Benepali (etanercept)
Simponi (golimumab)
Remicade (infliximab) + Remsima/Inflectra (infliximab)
Inflectra (infliximab)
Flixabi (infliximab)
Rituxan (rituximab)
Actemra/RoActemra (toclizumab)
XELJANZ (tofacitnib)
Kineret (anakinra)
Stelara (ustekinumab)
Entyvio (vedolizumab)
Tysabri (natalizumab)
Cosentyx (secukinumab)
Taltz (ixekizumab)

Drug Cost Analysis

BRIC Immunology Market Overview
Introduction
Currency Exchange Rate

BRIC Immunology Market - By Diseases
Market Overview
Rheumatoid Arthritis
Crohn’s Disease
Ankylosing Spondylitis
Psoriasis
Ulcerative Colitis

BRIC Immunology Market - By Treatments
Market Overview
Biologics (Biologic DMARDS)
Non-biologics (corticosteroids, NSAIDs, tDMARDS & other non-biologic)

BRIC Immunology Biologics Segment Analysis - By Drugs
Rheumatoid Arthritis Drugs
Crohn’s Disease Drugs
Ankylosing Spondylitis Drugs
Psoriasis Drugs
Ulcerative Colitis Drugs

BRIC Immunology Biologics Segment Analysis - By Mechanism Of Action (MOA)
TNF
JFK
Others

Country Profiles
Brazil
Market Overview
Drivers & Limiters
Russia
Market Overview
Drivers & Limiters
India
Market Overview
Drivers & Limiters
China
Market Overview
Drivers & Limiters

Competitive Landscape
Mergers & Acquisitions
Collaborations & Agreements
Market Shares & Competitive Analysis – by key players

Company Profiles
AbbVie Inc.
Business Overview
Product Portfoilio
Financials
SWOT Analysis
AstraZeneca Plc
Business Overview
Product Portfoilio
Financials
SWOT Analysis
F. Hoffmann-La Roche Ltd
Business Overview
Product Portfoilio
Financials
SWOT Analysis
Johnson & Johnson
Business Overview
Product Portfoilio
Financials
SWOT Analysis
Merck KGaA
Business Overview
Product Portfoilio
Financials
SWOT Analysis
Novartis AG
Business Overview
Product Portfoilio
Financials
SWOT Analysis
Pfizer Inc.
Business Overview
Product Portfoilio
Financials
SWOT Analysis
Takeda Pharmaceuticals
Business Overview
Product Portfoilio
Financials
SWOT Analysis
UCB S.A.
Business Overview
Product Portfoilio
Financials
SWOT Analysis

Future Outlook of the Market

Abbreviations

Appendix: Press Releases
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • AbbVie Inc.
  • AstraZeneca Plc
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc.
  • Takeda Pharmaceuticals
  • UCB S.A.
Please Note: Not all companies are currently active in every segment or sub-report from this suite.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll